]i) was studied in fura-2-loaded cells. Cell contraction was studied by assessing wrinkle formation and myosin light chain II (MLC II) phosphorylation. Cell proliferation and collagen-␣1(I) expression were assessed by [ 3 H]thymidine incorporation and quantitative PCR, respectively. NF-B activation was assessed by luciferase reporter gene and p65 nuclear translocation. Chemokine secretion was assessed by ELISA. Normal human livers expressed ␣1A-adrenoceptors, which were markedly upregulated in livers with advanced fibrosis. Activated human HSC expressed ␣1A-adrenoceptors. NE induced multiple rapid [Ca 2ϩ ]i oscillations (Ca 2ϩ spikes). Prazosin (␣1-blocker) completely prevented NE-induced Ca 2ϩ spikes, whereas propranolol (nonspecific ␤-blocker) partially attenuated this effect. NE caused phosphorylation of MLC II and cell contraction. In contrast, NE did not affect cell proliferation or collagen-␣1(I) expression. Importantly, NE stimulated the secretion of inflammatory chemokines (RANTES and interleukin-8) in a dose-dependent manner. Prazosin blocked NE-induced chemokine secretion. NE stimulated NF-B activation. BAY 11-7082, a specific NF-B inhibitor, blocked NE-induced chemokine secretion. We conclude that NE stimulates NF-B and induces cell contraction and proinflammatory effects in human HSC. Catecholamines may participate in the pathogenesis of portal hypertension and liver fibrosis by targeting HSC.
CATECHOLAMINES regulate a number of physiological functions in the liver. The normal human liver contains abundant sympathetic innervation, and circulating catecholamines regulate hepatic vascular tone as well as hepatic metabolic functions (10, 13, 43) . In patients with cirrhosis, catecholamines may participate in the pathogenesis of portal hypertension. In these patients, elevated serum catecholamines are believed to contribute to the increased intrahepatic vascular resistance to blood flow (4, 16) . Moreover, ␣-and ␤-adrenoceptor blockers markedly decrease portal pressure. The effect of nonselective ␤-blockers is mainly mediated by a reduction in portal venous blood flow, whereas the beneficial effects of ␣ 1 -receptor blockers is basically due to a reduction in intrahepatic resistance (3, 13) . In rats with experimentally induced cirrhosis, ␣ 1 -adrenoceptor agonists increase intrahepatic vascular resistance (17) . We hypothesized that ␣ 1 -adrenoceptors induce vasoactive effects in contractile (myofibroblastic) hepatic cell types, which might mediate changes in vascular tone in advanced liver diseases.
Besides their role in the regulation of vascular tone, catecholamines seem to be involved in the wound healing response to injury (11, 15) . Locally released catecholamines regulate key biological features of the tissue repair process, including myofibroblast proliferation and collagen secretion (1, 2) . Therefore, catecholamines are currently viewed as a system that participates in the local response to chronic injury. Recent evidence suggests that catecholamines may participate in the pathogenesis of liver fibrogenesis (29) . Experimentally induced liver fibrosis is enhanced in spontaneously hypertensive rats, which have elevated serum levels of catecholamines (21) . Moreover, both chemical sympathectomy and treatment with prazosin, an ␣ 1 -adrenoceptor blocker, attenuate experimentally induced liver fibrosis in rats (15, 30) . Finally, genetic ablation of the sympathetic nervous system (SNS) reduces liver fibrosis in mice (32) . Moreover, it has been shown that rodent hepatic stellate cells (HSC) express some adrenoceptor subtypes and that stimulation with norepinephrine (NE) induces proliferation and collagen gene expression (32, 33) .
The cell types mediating the beneficial effects of ␣ 1 -adrenoceptor blockers on portal hypertension and liver fibrosis are unknown. HSC are potential targets for the vasoactive actions of catecholamines in the liver. Contraction of HSC in response to vasoconstrictors (i.e., endothelin-1 and angiotensin II) is believed to contribute to the increased resistance to blood flow in advanced chronic liver diseases (6, (35) (36) (37) . Moreover, activated HSC secrete large amounts of collagen I as well as inflammatory mediators in chronic liver diseases, regulating fibrogenesis and inflammation (27) . We hypothesized that NE, a major catecholamine, induces vasoactive effects on activated HSC. Besides this action, we explored whether NE also regulates fibrogenic and proinflammatory actions in these cells.
MATERIALS AND METHODS
Human liver specimens and HSC isolation. Human cirrhotic livers were obtained from liver explants at the time of liver transplantation from patients with end-stage liver disease due to hepatitis C virus infection (n ϭ 5). Human control livers were obtained from resections of liver metastasis of colon cancer (n ϭ 5). Human HSC were isolated from fragments of normal livers as described in detail previously (6) . Experiments were performed with HSC activated in culture (after the second serial passage). A subset of experiments was performed in activated nonpassaged HSC. The immunocytochemistry studies were performed also in HSC freshly isolated from normal human livers (quiescent phenotype). In all cell cultures, no staining was found for CD45, factor VIII-related antigens, and cam 5.2 (Dako, Glostrup, Denmark), indicating the absence of mono/macrophagic, endothelial, and epithelial cells. Cells were cultured in standard conditions in Iscove's modified Dulbecco's medium (BioWhittaker, Verviers, Belgium) containing 15% FCS. Cells were serum starved for at least 12 h before the experiments. The protocol was approved by the Investigational Review Board of the Hospital Clínic of Barcelona.
Immunocytochemistry studies. Cultured HSC were fixed in methanol at Ϫ20°C for 10 min, blocked in PBS containing 0.1% BSA for 30 min, and incubated with anti-p65 or anti-␣ 1A-adrenoceptor for 1 h (Santa Cruz Biotechnology, Santa Cruz, CA). Cells were incubated with Cy3-or fluorescein-labeled secondary antibody for 1 h. An isotype-matched antibody was used as a negative control. Cells were analyzed with a Leica TCS SL laser scanning confocal spectral microscope (Leica Microsystems Heidelberg, Mannheim, Germany) at a wavelength of 500 -535 nm.
Measurement of intracellular Ca 2ϩ concentration. Changes in intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) were measured in fura-2 (Calbiochem, San Diego, CA)-loaded cells with an inverted epifluorescence microscope as described in detail previously (6) . A representative experiment was performed in fluo-4-loaded cells in a confocal spectral microscope. Cells were tested with NE, prazosin, and ␣1A-, ␣2B-, and ␤2-receptors were detected in HSC and whole liver, as assessed by RT-PCR. ␣1B-, ␣2A-, and ␤1-receptors were not detected in HSC but were amplified in mRNA isolated from human livers. GAPDH was amplified as a housekeeping gene to assess correct amplification (data not shown). B: detection of ␣1A-receptor in HSC freshly isolated from normal human livers (quiescent). Green staining shows ␣1A-receptor expression. C: detection of ␣1A-receptor in HSC activated after prolonged culture by immunocytochemistry. Note the ␣1A-adrenoceptor expression at the cell membrane. A negative control using an isotype-matched primary antibody was performed (D). 
propranolol (Sigma, St. Louis, MO). To study the Ca 2ϩ source, experiments were performed with and without extracellular Ca 2ϩ in selected groups. To deplete intracellular Ca 2ϩ stores, cells were incubated with thapsigargin (Sigma) for 20 min before NE stimulation. Cells were considered to be responders when [Ca 2ϩ ]i increased Ͼ50% above the resting value.
Assessment of cellular contraction. The contractile responses of cultured HSC to NE were evaluated by wrinkle formation (19, 24) . A thin layer of the polydimethyl siloxane (12.500 cP; Sigma) was spread on microscope coverslips. The silicone fluid layer was briefly heated on a low flame from a Bunsen burner to promote cross-linking of the silicone fluid surface while the overlying non-cross-linked fluid served as a lubricant and allowed the surface to move independently of the coverslip. Cells plated on the silicone rubber membrane showed basal wrinkles after 2-3 days in culture. Cells were photographed every 5 min on an Olympus IX70 inverted phase-contrast microscope with a digital charge-coupled device camera (Hamamatsu, Shizuoka, Japan) and stimulated with the agonists to assess cellular contraction by wrinkle formation. Cell contraction was considered to occur when there was a significant increase in the number of wrinkles or an increase in the length of the preexisting ones.
Gene expression assays. RNA was isolated from activated HSC with TRIzol (Life Technologies, Rockville, MD). PCR primer pairs were designed to amplify GAPDH and ␣ 1A-, ␣1B-, ␣2A-, ␣2B-, ␤1-, and ␤2-adrenoceptors (Table 1) . Quantitative PCR was performed with predesigned Assays-on-Demand TaqMan probes and primer pairs for collagen-␣ 1(I) and ribosomal subunit 18S. Information on these Assays-on-Demand is available at http:// myscience.appliedbiosystems.com/cdsEntry/Form/gene_expression_ keyword.jsp. TaqMan reactions were carried out in duplicate on an ABI PRISM 7900 machine (Applied Biosystems, Foster City, CA). 000 ) and Ad5GFP (MOI 1,000) for 12 h in DMEM containing 0.5% FCS. After infection, the medium was replaced with medium containing 0.5% FCS, and the culture was continued for an additional 8 h before the individual experiments were performed.
NF-B-responsive luciferase assay. HSC were infected with Ad5NF-BLuc for 12 h. Medium was replaced, and cells were stimulated with agonists for 8 h. NF-B-mediated transcriptional induction was assessed with the luciferase assay system (BD Pharmingen, San Diego, CA). Luciferase activity (relative light units) was normalized to the protein concentration.
Electrophoretic mobility shift assay. Cell nuclear proteins were extracted as described previously (8) . Eight micrograms of nuclear proteins were incubated with 100 pg of a 32 P-labeled probe containing the activator protein-1 (AP-1) consensus site (5Ј-GTAAAGCAT-GAGTCAGACACCTC-3Ј) in buffer containing (in mM) 10 HEPES (pH 7.8), 2 MgCl2, 50 KCl, 1 DTT, and 0.1 EDTA with 20% glycerol in the presence of single-stranded oligonucleotide (25 g/ml) and poly(dI-dC) (25 g/ml) for 20 min at room temperature. For the competition assay, one sample was incubated with 10 ng of unlabeled probe.
Western blot analysis. Whole cell extracts were obtained in Triton lysis buffer containing protease and phosphatase inhibitors. Twentyfive micrograms were loaded onto 10% or 15% SDS-acrylamide gels and blotted onto nitrocellulose membranes. Membranes were then incubated with antibodies against SAPK/JNK, phospho-SAPK/JNK, p44/42 MAPK (ERK), phospho-ERK, phospho-myosin light chain II (MLC II) (Cell Signaling, Beverly, MA), and ␣1A-adrenoceptor (Santa Cruz Biotechnology). After an extensive wash, membranes were incubated with blocking buffer containing horseradish peroxidase-conjugated secondary antibody. Proteins were detected by enhanced chemiluminescence (ECL, Amersham).
Data analysis. Data are representative of at least three experiments. Results are expressed as means ϩ SD. Statistical analysis was performed by Student's t-test and ANOVA. Statistical analysis was performed using SPSS software (Chicago, IL).
RESULTS
␣ 1A -Adrenergic receptors are expressed in human HSC and are upregulated in human fibrotic livers. We first assessed the expression of adrenoceptors in human HSC by RT-PCR. Cultured human HSC expressed ␣ 1A -, ␣ 2B -, and ␤ 2 -adrenoceptors (Fig. 1A) . In contrast, ␣ 1B -, ␣ 2A -, and ␤ 1 -adrenoceptors were not expressed in HSC but were detected in RNA obtained from the total human liver. Because ␣ 1 -receptors mediate key biological effects of the SNS in fibrogenic cell types (15, 38) , we further investigated their expression in HSC as well as in normal and fibrotic human liver specimens. Both quiescent and culture-activated HSC contained ␣ 1A -receptors, as assessed by immunocytochemistry (Fig. 1, B-D) . Moreover, Western blot analysis of whole liver extracts revealed that normal human livers express ␣ 1A -receptors, which are markedly upregulated in livers with advanced fibrosis (Fig. 2) . These results suggest that ␣ 1A -receptors are upregulated during liver fibrogenesis and that HSC are potential targets for adrenergic agonists and antagonists.
NE induces Ca 2ϩ spikes and cell contraction in human HSC. We next stimulated HSC with NE, a major neurotransmitter of the SNS. Stimulation of cells with NE (10 M) increased [Ca 2ϩ ] i in fura-2-loaded HSC (Table 2 and Fig. 3, A and D (Fig. 3C) . Similar results were obtained with nonpassaged cells activated in culture (data not shown). We next explored whether NE induces cell contraction. After 5 min, NE induced MLC II phosphorylation, which is a known prerequisite for cell contraction (20, 44) (Fig. 3E) . Preincubation with 10 M BAPTA-AM did not significantly modify MLC II phosphorylation, suggesting that it could be Ca 2ϩ independent (data not shown). Moreover, we found that stimulation with NE induced cell contraction, as assessed by wrinkle formation (Fig. 3F) (Fig. 4A) . Stimulation with phenylephrine or terbutaline (␣-and ␤-receptor agonists, respectively) did not affect cell proliferation (data not shown).
To elucidate whether NE regulates agonist-induced cell proliferation, HSC were pretreated with NE (10 M) and then challenged with PDGF-BB (20 ng/ml), a potent mitogen for these cells. NE pretreatment did not affect PDGF-induced mitogenic effects. These results indicate that NE is not mitogenic for human HSC.
Effect of NE on gene expression of collagen-␣ 1 (I) in human HSC. We next investigated whether NE regulates the expression of collagen-␣ 1 (I), the main extracellular protein found in fibrotic human livers. Stimulation of cells with NE (10 M) did not affect collagen expression, as assessed by quantitative PCR (Fig. 4B) . These results suggest that NE does not directly regulate collagen synthesis in activated human HSC.
NE stimulates chemokine production by human HSC. We next investigated whether NE regulates the inflammatory actions of HSC by stimulating chemokine secretion. NE (10 M) induced a significant increase in secretion of IL-8 and RANTES, which are chemokines potentially involved in liver fibrogenesis (34, 40) , to the culture medium (Fig. 5A) . Preincubation of cells with prazosin markedly reduced both IL-8 and RANTES secretion. Propranolol also attenuated NE-induced chemokine production, yet only RANTES secretion was significantly reduced. These results suggest that the inflammatory actions of NE on human HSC could be mediated by both ␣ 1 -and ␤-adrenoceptors.
Effect of NE on intracellular signaling pathways in human HSC. Finally, we explored the effect of NE on intracellular pathways known to regulate the inflammatory actions in human HSC (8, 41) . These pathways include MAPK and the transcription factors NF-B and AP-1. NE (10 M) induced a transient increase in ERK and SAPK/JNK phosphorylation, as assessed by Western blot analysis (Fig. 6A) . NE activated NF-B, as indicated by increased NF-B-dependent gene expression as well as nuclear translocation of the heterodimer p50/p65 (Fig.  6, B and C) . In addition, NE increased TNF-␣-induced NF-B activation, suggesting that it could amplify the inflammatory response evoked by other cytokines (data not shown). Finally, NE stimulated AP-1 DNA binding, as assessed by the electrophoretic mobility shift assay (Fig. 6D) . To elucidate the role of these signaling pathways on chemokine production, HSC were preincubated with specific antagonists before NE stimulation. Preincubation of cells with BAY 11-7082 (a NF-B inhibitor), but not with SP-600125 (a JNK inhibitor) and PD-231445 (an ERK inhibitor), attenuated IL-8 secretion (Fig. 5B) . Moreover, transfection with Ad5IB reduced IL-8 production, confirming NF-B involvement (Fig. 5C ). These data strongly indicate that NE exerts proinflammatory actions in human HSC through NF-B activation.
DISCUSSION
In the present study, we investigated the biological effects of NE in human HSC. We provide evidence that HSC express some ␣-and ␤-receptor subtypes. NE stimulates key intracellular signaling pathways in these cells and induces cell contraction and proinflammatory actions. These actions are mainly mediated by ␣ 1 -receptors, although ␤-receptors also modulate some of the effects evoked by NE. Moreover, ␣ 1 -receptors are markedly upregulated in human fibrotic livers. These results suggest that HSC are potential targets for the pathogenic effect of catecholamines in the liver, in keeping with recent data indicating that catecholamines not only regulate vascular ho- meostasis but also contribute to tissue repair and inflammation (11, 15, 30, 31) .
The hallmark biological action of NE in vascular cell types is to induce Ca 2ϩ increase and cell contraction. This effect has been extensively studied in mesangial cells and vascular smooth muscle cells (18, 26) . Similarly, a large number of studies have investigated the vasoactive effects of vasoconstrictors in cultured human HSC, including angiotensin II, endothelin-1, thrombin, and leukotriene D 4 (36) . Currently, studies using activated HSC are widely used to investigate the cellular basis of portal hypertension to identify potential targets for therapy. Surprisingly, little information is available on the actions of adrenergic agonists in these cells. Here, we provide evidence that NE is a potent agonist for human HSC to induce [Ca 2ϩ ] i increase. An intriguing finding of the present study is that the Ca 2ϩ response pattern evoked by NE markedly differs from that observed with other vasoconstrictors. Previously, we (6) showed that angiotensin II induces an abrupt [Ca 2ϩ ] i increase followed by a sustained phase. This effect was mainly due to the entrance of Ca 2ϩ from the extracellular space through voltage-operated Ca 2ϩ channels. Interestingly, the effect of NE on [Ca 2ϩ ] i consists of numerous Ca 2ϩ spikes. Baseline Ca 2ϩ spikes are characterized by rapidly rising transient increases in [Ca 2ϩ ] i , rising from a baseline that is close to the resting concentration (9) . This pattern of response has been described in many cells in response to hormones and neurotransmitters (18, 25 A relevant finding of the present study is that NE stimulates key intracellular signaling pathways implicated in the pathogenesis of hepatic inflammation and fibrogenesis. These pathways include NF-B, JNK/AP-1, and ERK. Importantly, NE enhances chemokine secretion in a NF-B-dependent manner. Besides their role in collagen synthesis, recent data suggest that activated HSC play a supportive role in the inflammatory response to injury (27) . These cells proliferate at the areas of liver injury, and cross-talk between HSC and infiltrating leukocytes is likely to occur. HSC can present antigens, express cell adhesion molecules, regulate lymphocyte proliferation, and secrete powerful chemokines such as IL-8 and RANTES (27, 42) . On the other hand, mediators derived from lymphocytes (e.g., CD40 ligand, RANTES) can regulate HSC biological functions and stimulate their fibrogenic potential (40, 41) . Therefore, by stimulating chemokine secretion, NE may enhance inflammation in chronic liver diseases. Whether NE also exerts proinflammatory actions in other nonparenchymal hepatic cell types (i.e., Kupffer cells and sinusoidal endothelial cells) is unknown and deserves further investigation.
In the present study, despite the possible proinflammatory effect of NE, we did not find a direct fibrogenic effect of NE on collagen expression. In rodent early-cultured HSC, NE stimulates collagen secretion, suggesting that it directly induces fibrogenic effects in these cells (32, 33) . These discrepant results can be explained by the fact that we used passaged, fully activated human HSC. In this cell phenotype, collagen is highly expressed and fibrogenic agonists commonly fail to further increase its expression. Other biological functions, such as chemokine secretion, can be stimulated by inflammatory mediators (40, 41) . However, it is well known that liver inflammation precedes and promotes the progression of liver fibrosis, and there is a positive correlation between the degree of sustained hepatic inflammation and the progression of fibrosis. Moreover, substances inhibiting the inflammatory response of the liver also limit fibrogenesis (5) . Therefore, we speculate that the proinflammatory effect of NE on HSC may play a role in promoting hepatic inflammation in patients with chronic liver diseases, thus favoring fibrosis development.
The biological effects of NE in HSC may have pathophysiological consequences. First, contraction of activated HSC is believed to increase intrahepatic vascular resistance in the cirrhotic liver and contribute to the pathogenesis of portal hypertension (37) . The finding that NE induces contraction in HSC may explain, at least in part, the effects of catecholamines in regulating intrahepatic vascular resistance in cirrhosis. Moreover, the fact that HSC synthesize NE suggests that not only may an endocrine pathways regulate HSC contractility but an autocrine/paracrine system may also be involved (32) . Further studies should study this hypothesis. Our finding that NE enhances chemokine secretion in HSC suggests that catecholamines may exert proinflammatory effects in the liver. The proinflammatory effect of NE on HSC has not been previously described in other cell types. The finding that NE may promote proinflammatory actions in HSC expands the traditional view of the SNS as a system that basically regulates systemic and hepatic hemodynamics.
In summary, the results of the present study indicate that NE mediates vasoactive and proinflammatory actions in human HSC mainly through ␣ 1 -adrenoceptors. Because HSC are able to synthesize adrenergic agonists and the SNS is activated in patients with advanced liver fibrosis, these findings suggest that catecholamines may increase intrahepatic vascular resistance and promote inflammatory actions by targeting HSC. Our data explain, at least in part, the mechanisms underlying the beneficial effects of ␣ 1 -receptor antagonists in the treatment of portal hypertension and suggest the potential use of these drugs to modulate hepatic inflammation and subsequent fibrogenesis.
